Getz Pharma
Getz Pharma
Explore linked clinical trials.8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Faisalabad Initiative of Research and Management of NCDs | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Not yet recruiting | Not stated | 2026-06-30 | NCT07676214 | |
| CGM Experience, Preferences & Blood Glucose Parameters | Female Urogenital Diseases and Pregnancy Complications, Nutritional and Metabolic Diseases, Urogenital Diseases, diabetes mellitus, endocrine system disorder, gestational diabetes, glucose intolerance, glucose metabolism disease, hyperglycemia, metabolic disease, pregnancy disorder | Not yet recruiting | Not stated | 2026-05-26 | NCT07607015 | |
| Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2026-01-22 | NCT05164263 | |
| Acotiamide vs Itopride in Postprandial Distress Syndrome | Postprandial Distress Syndrome | Not yet recruiting | Phase 3 | 2025-09-23 | NCT07174297 | |
| Diabetes Foot Africa Region Registry | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease | Not yet recruiting | Not stated | 2025-06-22 | NCT07031141 | |
| Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD | Body Weight, Body Weight Changes, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cirrhosis of liver, fatty liver disease, liver disorder | Recruiting | Phase 4 | 2025-03-21 | NCT05644717 | |
| Classification of Adult-onset Diabetes in Five Subgroups in Pakistani Population | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus, type 2 diabetes mellitus | Not yet recruiting | Not stated | 2024-11-26 | NCT06706609 | |
| Pakistan Study of Premature Coronary Atherosclerosis in Young Adults | Arterial Occlusive Diseases, Nutritional and Metabolic Diseases, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Atherosclerotic, arteriosclerosis disorder, atherosclerosis, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypertensive disorder, metabolic disease, nervous system disorder, stroke disorder, type 2 diabetes mellitus, vascular disorder | Recruiting | Not stated | 2023-04-07 | NCT05156736 |